Bandingkan Harga & Kinerja Indo Pureco Pratama Tbk. (IPPE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Pureco Pratama Tbk. dan Organon Pharma Indonesia Tbk.: Indo Pureco Pratama Tbk. diperdagangkan di Rp14 (kapitalisasi pasar 64,4 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| IPPE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 64,4 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Pureco Pratama Tbk.
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Selengkapnya di halaman IPPE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
